In a recent study, EGF-conjugated hybrid lipid polymer nanoparticles (LPN) were fabricated to co-deliver docetaxel (DTX) and RSV in non-small cell lung cancer (NSCLC). This evidence concerns the gene EGF and non-small cell lung carcinoma.